相似文献
1
The interneuron hypothesis of amyotrophic lateral sclerosis.
Brain. 2025 Apr 3;148(4):1045-1046. doi: 10.1093/brain/awaf104.
2
Cortical interneuron-mediated inhibition delays the onset of amyotrophic lateral sclerosis.
Brain. 2020 Mar 1;143(3):800-810. doi: 10.1093/brain/awaa034.
3
MRI-guided histology of TDP-43 knock-in mice implicates parvalbumin interneuron loss, impaired neurogenesis and aberrant neurodevelopment in amyotrophic lateral sclerosis-frontotemporal dementia.
Brain Commun. 2021 May 27;3(2):fcab114. doi: 10.1093/braincomms/fcab114. eCollection 2021.
4
Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice: a quantitative confocal analysis.
Am J Pathol. 2009 Feb;174(2):574-85. doi: 10.2353/ajpath.2009.080557. Epub 2008 Dec 30.
5
Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities.
Neurodegener Dis Manag. 2015 Dec;5(6):511-25. doi: 10.2217/nmt.15.49. Epub 2015 Nov 30.
6
How do we get from hyperexcitability to excitotoxicity in amyotrophic lateral sclerosis?
Brain. 2024 May 3;147(5):1610-1621. doi: 10.1093/brain/awae039.
7
The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis.
J Clin Neurosci. 2016 May;27:110-3. doi: 10.1016/j.jocn.2015.08.044. Epub 2016 Jan 4.
8
The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications.
Brain. 2020 Jun 1;143(6):1651-1673. doi: 10.1093/brain/awaa022.
9
Amyotrophic lateral sclerosis and glutamate.
Restor Neurol Neurosci. 1998;13(1-2):59-67.
10
Direct interrogation of cortical interneuron circuits in amyotrophic lateral sclerosis.
Brain. 2025 Apr 3;148(4):1169-1179. doi: 10.1093/brain/awae317.
本文引用的文献
1
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data.
Cell Genom. 2024 Nov 13;4(11):100679. doi: 10.1016/j.xgen.2024.100679. Epub 2024 Oct 21.
2
Direct interrogation of cortical interneuron circuits in amyotrophic lateral sclerosis.
Brain. 2025 Apr 3;148(4):1169-1179. doi: 10.1093/brain/awae317.
3
Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types.
Sci Adv. 2021 Jan 15;7(3). doi: 10.1126/sciadv.abd9036. Print 2021 Jan.
4
Hyperactive somatostatin interneurons contribute to excitotoxicity in neurodegenerative disorders.
Nat Neurosci. 2016 Apr;19(4):557-559. doi: 10.1038/nn.4257. Epub 2016 Feb 22.
5
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study.
Amyotroph Lateral Scler. 2008 Feb;9(1):43-9. doi: 10.1080/17482960701737716.
6
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET.
Brain. 2005 Jun;128(Pt 6):1323-9. doi: 10.1093/brain/awh509. Epub 2005 Apr 20.
7
Cortical selective vulnerability in motor neuron disease: a morphometric study.
Brain. 2004 Jun;127(Pt 6):1237-51. doi: 10.1093/brain/awh132. Epub 2004 May 6.
Zotero 插件